Mckinley Capital Management LLC Insulet Corp Transaction History

Mckinley Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$127.77 - $221.42 $1.16 Million - $2 Million	9,040 New	9,040 $1.96 Million
Q2 2023 Aug 09, 2023	SELL	$272.48 - $330.23 $490,464 - $594,414	-1,800 Reduced 11.83%	13,420 $3.87 Million
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $1.08 Million - $1.35 Million	4,810 Added 46.21%	15,220 $3.49 Million
Q1 2022 Apr 29, 2022	BUY	$194.8 - $275.7 $2.03 Million - $2.87 Million	10,410 New	10,410 $2.77 Million

676

64M

365K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $17B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.